PropThink: Sickle Cell Drug Finding New Opportunity at ADVENTRX Pharmaceuticals

[ACN Newswire] – With Orphan Drug status and a largely-unmet medical need for its primary indication, ADVENTRX Pharmaceuticals (AMEX:ANX) expects its lead candidate, ANX-188, to be the company’s most important asset in … more

View todays social media effects on BMY

View the latest stocks trending across Twitter. Click to view dashboard